Pulmonary hypertension can only be diagnosed now through an invasive right heart catheterization. A research team sought to evaluate the effectiveness of a
COVID-19: 5 blood proteins predict critical illness and death
Written by James Kingsland on March 3, 2021 Fact checked by Catherine Carver, MPH
Five key proteins in a person’s blood may predict their risk of developing severe COVID-19. Thana Prasongsin/Getty Images
A study suggests that among people hospitalized for COVID-19, blood levels of five proteins are higher in those who will go on to require critical care.
These proteins are associated with a type of immune cell that may promote excessive inflammation and blood clotting in the lungs.
Some of the same proteins are at elevated levels in people with obesity.
Study reveals blood tests can offer early indicator of severe COVID-19 ANI | Updated: Mar 02, 2021 09:44 IST
Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19patients.
The findings of the study were published in the journal Blood Advances .
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. However, this study focuses on biomarkers that can help predict severe outcomes in COVID-19patients.
Read Time:
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery.
New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. Patients with high levels of these markers were much more like to require care in the intensive care unit, require ventilation, or die due to their COVID-19, said Dr. Hyung Chun, the lead author, an associate professor of medicine in cardiovascular medicine and pathology and director of translational research at the Yale Pulmonary Vascular Disease Program.